Computer-aided detection and radiation therapy firm iCAD has received clearance from the U.S. Food and Drug Administration (FDA) for its new cervical applicator for use with the Xoft Axxent electronic brachytherapy system.
The applicator delivers high-dose-rate brachytherapy for intracavitary treatment of cancer of the uterus, cervix, endometrium, and vagina, according to the firm.
